Environmental Health and Safety
FEATURED REPORTS
WHAT'S NEW
-
Is it time to upgrade your environmental monitoring program?
by Clarkston Consulting
White paper
This white paper from Clarkston Consulting offers four item to highlight the potential benefits that a pharmaceutical company can experience from upgrading their environmental monitoring program.
-
Common hazardous waste issues in the life sciences industry
by Affygility Solutions
White paper
This white paper from Affygility Solutions discusses common hazardous waste issues in the state of Colorado and offers insights into those issues in order to maintain compliance and avoid violations.
REPORTS BY SUBTOPIC
There are currently no reports available for this topic.
Is it time to upgrade your environmental monitoring program?
By Clarkston Consulting
White paper
This white paper from Clarkston Consulting offers four item to highlight the potential benefits that a pharmaceutical company can experience from upgrading their environmental monitoring program.
There are currently no reports available for this topic.
Common hazardous waste issues in the life sciences industry
By Affygility Solutions
White paper
This white paper from Affygility Solutions discusses common hazardous waste issues in the state of Colorado and offers insights into those issues in order to maintain compliance and avoid violations.
Why Do you Need to be Concerned About Global Hazard Communications?
By American Industrial Hygiene Assn.
White paper
This white paper from the American Industrial Hygiene Association states that if material data safety sheets (MSDSs) are to remain a valuable tool in the protection of workers and others, all industrialized countries must work together to see that they contain the most reliable and accurate data available.
There are currently no reports available for this topic.
Econ-o-Tape Strips
By General Econopak Inc. (GEPCO)
Product collateral
General Econopak's Econ-o-Tape Strips are used for multiple applications including positive glove closure, secure boots, mending tears, seal stoppers, and slide prevention.
FDA Guidance for Industry : Manufacturing Biological Intermediates and ...
White paper
The former regulations at 21 CFR 600.11(e)(3) (§ 600.11(e)(3)) required that all work with spore-bearing microorganisms (spore-formers) be conducted in an entirely separate building, or in a completely walled-off portion of a multiproduct building. The Food and Drug Administration (FDA), modified the regulatory requirements for the manufacturing of biological products with spore-formers to...
